Skip to main content
Top
Published in: BMC Geriatrics 1/2015

Open Access 01-12-2015 | Research article

“Short term surgical complications after subthalamic deep brain stimulation for Parkinson’s disease: does old age matter?”

Authors: Vincenzo Levi, Giorgio Carrabba, Paolo Rampini, Marco Locatelli

Published in: BMC Geriatrics | Issue 1/2015

Login to get access

Abstract

Background

Patients aged 65 years and older are not traditionally considered optimal candidates for subthalamic deep brain stimulation (STN-DBS), mainly for their presumed increased incidence of surgical complications. The aim of this study was to assess STN-DBS surgery safety in relation to age.

Methods

A total of 107 consecutive patients undergoing bilateral STN-DBS at our institution between 2002 and 2014 were retrospectively stratified according to age in two groups (Young group < 65 years old; Elderly group ≥ 65 years old;). Rate of short-term surgical complications (within 90 days) was reviewed and compared between the two groups.

Results

Pre-operative baseline data were comparable between the two groups. The 90-days post-operative mortality rate was 0%. Overall incidence of complications related to surgery was 6,54%. In the Elderly group we observed 3 post-operative intra-cerebral haematomas (7,89%), 1 requiring urgent surgical evacuation. In the Young group we observed 2 post-operative asymptomatic intra-cerebral haematomas (2,89%) and 2 wound infections (2,89%), 1 requiring system removal. No others surgical complications were noticed in both groups.

Conclusions

Chronological age ≥ 65 years old should not be considered alone as exclusion criteria to STN-DBS surgery.
Literature
1.
go back to reference Robinson RA, Taghva A, Liu CY, Apuzzo ML. Surgery of the mind, mood and conscious state: an idea in evolution. World Neurosurg. 2013;80(3–4):S2–S26.CrossRef Robinson RA, Taghva A, Liu CY, Apuzzo ML. Surgery of the mind, mood and conscious state: an idea in evolution. World Neurosurg. 2013;80(3–4):S2–S26.CrossRef
2.
go back to reference Benabid AL, Koudsie A, Benazzouz A, Vercueil L, Fraix V, Chabardes S. Deep brain stimulation of the corpus luysi (subthalamic nucleus) and other targets in Parkinson's disease. Extension to new indications such as dystonia and epilepsy. J Neurol. 2001;248(3):III37–47.CrossRefPubMed Benabid AL, Koudsie A, Benazzouz A, Vercueil L, Fraix V, Chabardes S. Deep brain stimulation of the corpus luysi (subthalamic nucleus) and other targets in Parkinson's disease. Extension to new indications such as dystonia and epilepsy. J Neurol. 2001;248(3):III37–47.CrossRefPubMed
3.
go back to reference Hariz M, Blomstedt P, Zrinzo L. Future of brain stimulation: new targets, new indications, new technology. Mov Disord. 2013;28(13):1784–92.CrossRefPubMed Hariz M, Blomstedt P, Zrinzo L. Future of brain stimulation: new targets, new indications, new technology. Mov Disord. 2013;28(13):1784–92.CrossRefPubMed
4.
go back to reference Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003;349(20):1925–34.CrossRefPubMed Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003;349(20):1925–34.CrossRefPubMed
5.
go back to reference Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21(14):S290–304.CrossRefPubMed Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21(14):S290–304.CrossRefPubMed
6.
go back to reference Beric A, Kelly PJ, Rezai A, Sterio D, Mogilner A, Zonenshayn M, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg. 2001;77(1–4):73–8.PubMed Beric A, Kelly PJ, Rezai A, Sterio D, Mogilner A, Zonenshayn M, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg. 2001;77(1–4):73–8.PubMed
7.
go back to reference Okun MS, Kd F. Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS target. Expert Rev Neurother. 2010;10(12):1847–57.CrossRefPubMedPubMedCentral Okun MS, Kd F. Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS target. Expert Rev Neurother. 2010;10(12):1847–57.CrossRefPubMedPubMedCentral
8.
go back to reference Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, et al. Deep brain stimulation: preoperative issues. Mov Disord. 2006;21(14):S171–96.CrossRefPubMed Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, et al. Deep brain stimulation: preoperative issues. Mov Disord. 2006;21(14):S171–96.CrossRefPubMed
9.
go back to reference Ahmed NN, Sherman SJ, Vanwyck D. Frailty in Parkinson’s Disease and its clinical implications. Parkinsonism Relat Disord. 2008;14(4):334–7.CrossRefPubMed Ahmed NN, Sherman SJ, Vanwyck D. Frailty in Parkinson’s Disease and its clinical implications. Parkinsonism Relat Disord. 2008;14(4):334–7.CrossRefPubMed
10.
go back to reference Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson’s Disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.CrossRefPubMed Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson’s Disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.CrossRefPubMed
11.
go back to reference von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poew W. Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol. 2005;15:473–90.CrossRef von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poew W. Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol. 2005;15:473–90.CrossRef
12.
go back to reference Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384–6.CrossRefPubMed Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384–6.CrossRefPubMed
14.
go back to reference Chlon-Dominczak A, Kotowska IE, Kurkiewicz J, Stonawski M, Abramowska-Kmon A. Population ageing in Europe: facts, implications and policies. European Commission, DG R&I. 2014 doi:10.13140/2.1.5039.6806 Chlon-Dominczak A, Kotowska IE, Kurkiewicz J, Stonawski M, Abramowska-Kmon A. Population ageing in Europe: facts, implications and policies. European Commission, DG R&I. 2014 doi:10.​13140/​2.​1.​5039.​6806
15.
go back to reference Derost PP, Ouchchane L, Morand D, Ulla M, Llorca PM, Barget M, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology. 2007;68(17):1345–55.CrossRefPubMed Derost PP, Ouchchane L, Morand D, Ulla M, Llorca PM, Barget M, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology. 2007;68(17):1345–55.CrossRefPubMed
16.
go back to reference Parent B, Awan N, Berman SB, Suski V, Moore R, Crammond D, et al. The relevance of age and disease duration for intervention with subthalamic nucleus deep brain stimulation surgery in Parkinson disease. J Neurosurg. 2011;114(4):927–31.CrossRefPubMed Parent B, Awan N, Berman SB, Suski V, Moore R, Crammond D, et al. The relevance of age and disease duration for intervention with subthalamic nucleus deep brain stimulation surgery in Parkinson disease. J Neurosurg. 2011;114(4):927–31.CrossRefPubMed
17.
go back to reference Shalash A, Alexoudi A, Knudsen K, Volkmann J, Mehdorn M, Deuschl G. The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus. Parkinsonism Relat Disord. 2014;20:47–52.CrossRefPubMed Shalash A, Alexoudi A, Knudsen K, Volkmann J, Mehdorn M, Deuschl G. The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus. Parkinsonism Relat Disord. 2014;20:47–52.CrossRefPubMed
18.
go back to reference DeLong MR, Huang KT, Gallis J, Lokhnygina Y, Parente B, Hickey P, et al. Effect of advancing age on outcomes of deep brain stimulation for parkinson disease. Jama Neurol. 2014;71(10):1290–5.CrossRefPubMed DeLong MR, Huang KT, Gallis J, Lokhnygina Y, Parente B, Hickey P, et al. Effect of advancing age on outcomes of deep brain stimulation for parkinson disease. Jama Neurol. 2014;71(10):1290–5.CrossRefPubMed
20.
go back to reference Russmann H, Ghika J, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology. 2004;63(10):1952–4.CrossRefPubMed Russmann H, Ghika J, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology. 2004;63(10):1952–4.CrossRefPubMed
21.
go back to reference Umemura A, Oka Y, Okita K, Toyoda T, Matsukawa N, Yamada K. Predictive factors affecting early deterioration of axial symptoms after subthalamic nucleus stimulation in Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(9):582–4.CrossRefPubMed Umemura A, Oka Y, Okita K, Toyoda T, Matsukawa N, Yamada K. Predictive factors affecting early deterioration of axial symptoms after subthalamic nucleus stimulation in Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(9):582–4.CrossRefPubMed
22.
go back to reference Voges J, Hilker R, Bötzel K, Kiening KL, Kloss M, Kupsch A, et al. Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord. 2007;22(10):1486–9.CrossRefPubMed Voges J, Hilker R, Bötzel K, Kiening KL, Kloss M, Kupsch A, et al. Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord. 2007;22(10):1486–9.CrossRefPubMed
23.
go back to reference Partridge JS, Harari D, Dhesi JK. Frailty in the older surgical patient: a review. Age Ageing. 2012;41(2):142–7.CrossRefPubMed Partridge JS, Harari D, Dhesi JK. Frailty in the older surgical patient: a review. Age Ageing. 2012;41(2):142–7.CrossRefPubMed
24.
go back to reference Rughani AI, Hodaie M, Lozano AM. Acute complications of Movement Disorders Surgery: effects of age and comorbidities. Mov Disord. 2013;28(12):1161–7.CrossRef Rughani AI, Hodaie M, Lozano AM. Acute complications of Movement Disorders Surgery: effects of age and comorbidities. Mov Disord. 2013;28(12):1161–7.CrossRef
25.
go back to reference Moro E, Allert N, Eleopra R, Houeto JL, Phan TM, Stoevelaar H. A decision tool to support appropriate referral for deep brain stimulation in Parkinson’s disease. J Neurol. 2009;256:83–8.CrossRefPubMed Moro E, Allert N, Eleopra R, Houeto JL, Phan TM, Stoevelaar H. A decision tool to support appropriate referral for deep brain stimulation in Parkinson’s disease. J Neurol. 2009;256:83–8.CrossRefPubMed
26.
go back to reference Zrinzo L, Foltynie T, Limousin P, Hariz MI. Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg. 2012;116(1):84–94.CrossRefPubMed Zrinzo L, Foltynie T, Limousin P, Hariz MI. Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg. 2012;116(1):84–94.CrossRefPubMed
27.
go back to reference Ben-Haime S, Asaad WF, Gale JT, Eskandar EN. Risk factors for haemorrhage during microelectrode-guided deep brain stimulation and the introduction of an improved microelectrode design. Neurosurgery. 2009;64:754–62.CrossRef Ben-Haime S, Asaad WF, Gale JT, Eskandar EN. Risk factors for haemorrhage during microelectrode-guided deep brain stimulation and the introduction of an improved microelectrode design. Neurosurgery. 2009;64:754–62.CrossRef
Metadata
Title
“Short term surgical complications after subthalamic deep brain stimulation for Parkinson’s disease: does old age matter?”
Authors
Vincenzo Levi
Giorgio Carrabba
Paolo Rampini
Marco Locatelli
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2015
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-015-0112-2

Other articles of this Issue 1/2015

BMC Geriatrics 1/2015 Go to the issue